Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1903 1
1916 1
1923 1
1924 1
1925 9
1926 1
1928 1
1932 1
1934 1
1937 1
1938 3
1940 1
1942 3
1943 1
1945 51
1946 187
1947 208
1948 196
1949 205
1950 188
1951 274
1952 427
1953 767
1954 911
1955 932
1956 836
1957 559
1958 427
1959 413
1960 386
1961 382
1962 315
1963 255
1964 499
1965 482
1966 617
1967 905
1968 1317
1969 1385
1970 1432
1971 1517
1972 1636
1973 1740
1974 1919
1975 1651
1976 1524
1977 1461
1978 1384
1979 1622
1980 1627
1981 1535
1982 1692
1983 1773
1984 1950
1985 2140
1986 2037
1987 2209
1988 2403
1989 2500
1990 2670
1991 2593
1992 2594
1993 2777
1994 2846
1995 2699
1996 2654
1997 2842
1998 3133
1999 3088
2000 3580
2001 3602
2002 4009
2003 4350
2004 4649
2005 5017
2006 5468
2007 5539
2008 6031
2009 6111
2010 6249
2011 6514
2012 7059
2013 7410
2014 7485
2015 7806
2016 8012
2017 8175
2018 8420
2019 8769
2020 9704
2021 9990
2022 8730
2023 8232
2024 2736

Text availability

Article attribute

Article type

Publication date

Search Results

220,285 results

Results by year

Filters applied: . Clear all
Page 1
Lodenafil.
Alshehri YM, Al-Majed AA, Attwa MW, Bakheit AH. Alshehri YM, et al. Profiles Drug Subst Excip Relat Methodol. 2022;47:113-147. doi: 10.1016/bs.podrm.2021.10.004. Epub 2021 Dec 7. Profiles Drug Subst Excip Relat Methodol. 2022. PMID: 35396013 Review.
Lodenafil is a class of drugs called an inhibitor of PDE5 which also include a wide range of other erectile medicines, such as sildenafil, tadalafil and vardenafil. It is part of a new generation of PDE5 inhibitors that includes udenafil and avanafil. ...
Lodenafil is a class of drugs called an inhibitor of PDE5 which also include a wide range of other erectile medicines, such as sil …
Sildenafil in postprostatectomy erectile dysfunction (perspective).
Fode M, Jensen CFS, Østergren PB. Fode M, et al. Int J Impot Res. 2019 Mar;31(2):61-64. doi: 10.1038/s41443-018-0102-y. Epub 2019 Mar 5. Int J Impot Res. 2019. PMID: 30837719 Review.
Erectile dysfunction (ED) is a common side effect to radical prostatectomies, even with nerve-sparing procedures. ...Therefore, sildenafil should no longer be offered as a sole means of penile rehabilitation. ...
Erectile dysfunction (ED) is a common side effect to radical prostatectomies, even with nerve-sparing procedures. ...Therefore …
Erectile dysfunction and sildenafil citrate and cardiologists.
Kloner RA, Jarow JP. Kloner RA, et al. Am J Cardiol. 1999 Feb 15;83(4):576-82, A7. doi: 10.1016/s0002-9149(98)00916-3. Am J Cardiol. 1999. PMID: 10073864
Since the release of sildenafil citrate (Viagra), increasing numbers of patients are seeking treatment for erectile dysfunction (ED). ...The issue of cardiac deaths associated with sildenafil citrate and ways of potentially minimizing the …
Since the release of sildenafil citrate (Viagra), increasing numbers of patients are seeking treatment for erectile …
Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
Doggrell S. Doggrell S. Int J Impot Res. 2007 May-Jun;19(3):281-95. doi: 10.1038/sj.ijir.3901525. Epub 2006 Dec 21. Int J Impot Res. 2007. PMID: 17183346 Review.
Erectile dysfunction (ED) affects up to 50% of men between the ages of 40 and 70 years of age. ...Although nonarteritic anterior ischaemic neuropathy has been reported in some users of the PDE5 inhibitors, there is no conclusive evidence that PDE5 inhibitors cause t …
Erectile dysfunction (ED) affects up to 50% of men between the ages of 40 and 70 years of age. ...Although nonarteritic anteri …
Efficacy and Safety of Sildenafil by Age in Men With Erectile Dysfunction.
Goldstein I, Tseng LJ, Creanga D, Stecher V, Kaminetsky JC. Goldstein I, et al. J Sex Med. 2016 May;13(5):852-9. doi: 10.1016/j.jsxm.2016.02.166. J Sex Med. 2016. PMID: 27114196
INTRODUCTION: Sildenafil, an oral phosphodiesterase type 5 inhibitor, has been extensively investigated for the treatment of erectile dysfunction in randomized controlled trials. ...The most common adverse events with sildenafil were headache and flush …
INTRODUCTION: Sildenafil, an oral phosphodiesterase type 5 inhibitor, has been extensively investigated for the treatment of erect …
Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports.
Markou S, Perimenis P, Gyftopoulos K, Athanasopoulos A, Barbalias G. Markou S, et al. Int J Impot Res. 2004 Dec;16(6):470-8. doi: 10.1038/sj.ijir.3901258. Int J Impot Res. 2004. PMID: 15229625 Review.
Trials of the efficacy and safety of vardenafil in the treatment of male erectile dysfunction (ED) were meta-analysed. ...Vardenafil, in all treatment regimens, shows to possess superior efficacy to placebo in the treatment of patients with erectile …
Trials of the efficacy and safety of vardenafil in the treatment of male erectile dysfunction (ED) were meta-analysed. …
Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction.
Doggrell SA. Doggrell SA. Expert Opin Pharmacother. 2005 Jan;6(1):75-84. doi: 10.1517/14656566.6.1.75. Expert Opin Pharmacother. 2005. PMID: 15709885 Review.
Erectile dysfunction (ED) affects up to 50% of men, between 40 and 70 years of age. ...Vardenafil is similarly effective to sildenafil in the treatment of ED. ...
Erectile dysfunction (ED) affects up to 50% of men, between 40 and 70 years of age. ...Vardenafil is similarly effectiv …
Erectile dysfunction.
O'Leary M; Bazian Ltd. O'Leary M, et al. Clin Evid. 2002 Dec;(8):872-80. Clin Evid. 2002. PMID: 15259177 Updated. Review. No abstract available.
Erectile dysfunction.
Lue TF. Lue TF. N Engl J Med. 2000 Jun 15;342(24):1802-13. doi: 10.1056/NEJM200006153422407. N Engl J Med. 2000. PMID: 10853004 Review. No abstract available.
Prostaglandins as a Topical Therapy for Erectile Dysfunction: A Comprehensive Review.
Hamzehnejadi M, Tavakoli MR, Homayouni F, Jahani Z, Rezaei M, Langarizadeh MA, Forootanfar H. Hamzehnejadi M, et al. Sex Med Rev. 2022 Oct;10(4):764-781. doi: 10.1016/j.sxmr.2022.06.004. Sex Med Rev. 2022. PMID: 36210096 Review.
INTRODUCTION: Erectile dysfunction (ED) is a substantial cause of dissatisfaction among many men. ...Hamzehnejadi M, Tavakoli MR, Homayoun F et al. Prostaglandins as a Topical Therapy for Erectile Dysfunction: A Comprehensive Review. Sex Med Rev …
INTRODUCTION: Erectile dysfunction (ED) is a substantial cause of dissatisfaction among many men. ...Hamzehnejadi M, Tavakoli …
220,285 results
You have reached the last available page of results. Please see the User Guide for more information.